Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

710
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
710
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

765
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
765
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

735
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
735
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blue Rubber Bleb Nevus Syndrome.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

The Many Faces of Nonthrombotic Pulmonary Artery Embolism.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same author

Clinical Outcomes of Ground-Glass Nodules Detected in a CT Lung Cancer Screening Program.

Radiology. Cardiothoracic imaging·2026
Same author

Clinically Relevant Findings in Lung Cancer Staging.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025
Same author

MRI Evaluation of Indeterminate Pulmonary Nodules.

Journal of computer assisted tomography·2025
Same author

Equal Outcomes for Patients with Ground-Glass Nodules Managed with Surveillance versus Surgical Resection.

Radiology·2025
Same journal

Invited Commentary: Postdeployment Monitoring of AI in Radiology: Beyond the Test Set.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same journal

Rosai-Dorfman Disease: Imaging and Updates.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same journal

Spectrum of Breast Sarcomas with Radiologic-Pathologic Correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same journal

Postdeployment Monitoring and Surveillance Methods, Guidelines, and Possibilities for AI in Radiology.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same journal

Clinical Correlation for Imaging of Left Ventricular Assist Devices.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
Same journal

Invited Commentary: Three-Piece Inflatable Penile Prosthesis: Imaging Insights Beyond the Operating Room.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026
See all related articles

Related Experiment Video

Updated: Jan 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Pneumonia in Immunocompromised Patients.

Silvia Arora1, Stephanie M Walker1, Kristopher W Cummings2

  • 1Brigham and Women's Hospital, Department of Radiology, 75 Francis St, Boston, MA 02115.

Radiographics : a Review Publication of the Radiological Society of North America, Inc
|November 26, 2025
PubMed
Summary
This summary is machine-generated.

The number of immunocompromised patients is rising, leading to increased pneumonia risk. Identifying the specific cause of pneumonia in these individuals is crucial for effective treatment and improved outcomes.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.0K

Related Experiment Videos

Last Updated: Jan 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.0K

Area of Science:

  • Medical Imaging
  • Infectious Diseases
  • Immunology

Background:

  • Increased survival in cancer patients and advancements in immune-modulating therapies have led to a growing population of immunocompromised individuals.
  • Pneumonia is a primary cause of infectious disease mortality in immunocompromised patients, necessitating accurate pathogen identification for treatment.

Purpose of the Study:

  • To correlate specific types of immunocompromise with potential opportunistic pathogens.
  • To describe imaging patterns of opportunistic pulmonary infections in immunocompromised patients.
  • To highlight the radiologist's role in diagnosing pulmonary diseases in immunocompromised individuals.

Main Methods:

  • Review of clinical settings and associated immunocompromise types.
  • Association of immunocompromise with specific opportunistic organisms.
  • Description of disease patterns in HIV patients based on CD4 cell counts.
  • Analysis of imaging findings for viral and fungal infections in neutropenic patients.

Main Results:

  • Different clinical settings present unique types of immunocompromise.
  • Specific opportunistic pathogens are linked to distinct immunocompromising conditions.
  • HIV infection patterns vary with CD4 cell counts.
  • Characteristic imaging features are associated with viral and fungal pneumonia in neutropenia.

Conclusions:

  • Understanding the type of immunocompromise is essential for diagnosing pneumonia in affected patients.
  • Radiologists can identify key imaging features of opportunistic pulmonary infections.
  • This knowledge aids in the differential diagnosis and management of pneumonia in immunocompromised individuals.